Akihiro Michihara Selected Research

pyrophosphomevalonate decarboxylase (diphosphomevalonate decarboxylase)

1/2015	Involvement of microRNA214 and transcriptional regulation in reductions in mevalonate pyrophosphate decarboxylase mRNA levels in stroke-prone spontaneously hypertensive rat livers.
10/2004	[Comparison of biochemical properties and protein level of mevalonate pyrophosphate decarboxylase between stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats].
6/2002	Comparison of subcellular distribution of mevalonate pyrophosphate decarboxylase between stroke-prone spontaneously hypertensive rat and Wistar Kyoto rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Michihara Research Topics

Disease

11	Stroke (Strokes) 03/2021 - 06/2002
2	Alcoholic Fatty Liver 03/2021 - 12/2020
2	Atherosclerosis 01/2021 - 04/2020
2	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 04/2020
2	Body Weight (Weight, Body) 06/2012 - 01/2010
2	Melanoma (Melanoma, Malignant) 01/2010 - 02/2007
1	Chronic Renal Insufficiency 01/2022
1	Fatty Liver 03/2021
1	Inflammation (Inflammations) 03/2021
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 01/2021
1	Ischemia 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2020
1	Alzheimer Disease (Alzheimer's Disease) 05/2020
1	Dyslipidemias (Dyslipidemia) 04/2020
1	Hypertension (High Blood Pressure) 02/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Cerebral Infarction 01/2018
1	Hemorrhage 10/2017
1	Cardiovascular Infections 05/2017
1	Diabetes Mellitus 05/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2012
1	Uremia 09/2009
1	Cerebral Hemorrhage 10/2004

Drug/Important Bio-Agent (IBA)

7	CholesterolIBA 12/2020 - 10/2004
4	EnzymesIBA 05/2020 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 10/2004
3	pyrophosphomevalonate decarboxylase (diphosphomevalonate decarboxylase)IBA 01/2015 - 06/2002
2	sacranIBA 01/2022 - 03/2021
2	Polysaccharides (Glycans)IBA 01/2022 - 03/2021
2	ClaudinsIBA 01/2021 - 10/2017
2	Small Interfering RNA (siRNA)IBA 05/2020 - 04/2020
2	ChitosanIBA 02/2019 - 06/2012
2	Peptides (Polypeptides)IBA 01/2018 - 05/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2015
2	CreatinineIBA 06/2012 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 06/2012 - 01/2010
1	LipidsIBA 03/2021
1	CytokinesIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	ChitinIBA 12/2020
1	OxysterolsIBA 05/2020
1	24-hydroxycholesterolIBA 05/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 04/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	olmesartanIBA 02/2019
1	CyclodextrinsIBA 02/2019
1	Delayed-Action PreparationsIBA 02/2019
1	Pharmaceutical PreparationsIBA 02/2019
1	Ether (Diethyl Ether)IBA 02/2019
1	TabletsIBA 02/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Tight Junction ProteinsIBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	Squalene Monooxygenase (Squalene Epoxidase)IBA 01/2015
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2015
1	IndicanIBA 06/2012
1	oxidized low density lipoproteinIBA 01/2010
1	Melanins (Melanin)IBA 01/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2010
1	TocotrienolsIBA 01/2010
1	Dihydrotachysterol (AT 10)IBA 01/2010
1	Triglycerides (Triacylglycerol)IBA 01/2010
1	Serum AlbuminIBA 09/2009
1	Lipoproteins (Lipoprotein)IBA 02/2007
1	GlucuronidaseIBA 02/2007
1	Lovastatin (Mevacor)FDA LinkGeneric 02/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2007

Therapy/Procedure

1	Nephrectomy 01/2022
1	Renal Dialysis (Hemodialysis) 09/2009